Back to search

Boston University

Novel statistical methods for multi-stage designs in clinical trials with high placebo response

Abstract

dc:description.abstract

Placebo response occurs when a patient perceives an improvement from the psychological effect of receiving treatment rather than from the therapy itself. High placebo response reduces drug-placebo differences and makes it challenging to demonstrate a statistically significant benefit of an active drug over placebo. Two-way enriched design (TED) and sequential enriched design (SED) are two designs to estimate treatment effect with the existence of placebo response. They are extensions of sequential parallel comparison design (SPCD) and have multiple stages with enrichment strategies. This work aims to propose novel analysis methods and evaluate their performances in the framework of TED and SED. TED is a two-stage, randomized, placebo-controlled design with enrichment in 'placebo non-responders' and 'drug responders'. We first consider the placebo non-response as a measurable binary characteristic, either present or absent in an individual. We then discuss the placebo non-response as a characteristic that exists in every subject to a certain degree. We propose to include it in the model as a weight. In addition, we consider placebo non-response and drug non-response as latent characteristics and introduce stochastic components in the classification of the subjects in the setting of TED. SED, as the only three-stage design, aims to exclude subjects who are 'placebo responders' and those who never respond to either treatment. Considering the complexity of this design, we critically appraise the performance of SED from different perspectives. We first test the robustness of SED by varying values of parameters. We then calculate the actual sample size and the proportion of the target population in the sample. We also apply the first two analysis methods to SED. We evaluate these novel methods on a wide range of simulated data scenarios in terms of type I error, mean squared error, and power. From the appraisals above, SED does not benefit from the additional stage. Therefore, in terms of design, we suggest implementing TED rather than SED when placebo response is a critical issue. In terms of the proposed analysis methods, the approach with stochastic components performs the best based on our evaluations, especially when the definition of response is uncertain.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Biostatistics
Grantor
Boston University
Year dc:date.issued
2020

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Liu, Yuyin
Advisor dc:contributor.advisor
  • Doros, Gheorghe
ORCID dc:identifier.orcid

Subjects

dc:subject × 7

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/39909

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Liu, Yuyin. Novel statistical methods for multi-stage designs in clinical trials with high placebo response. doctoral thesis, Boston University, 2020. https://hdl.handle.net/2144/39909